These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20368210)

  • 1. Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemia.
    Hermans MP; Ahn SA; Rousseau MF
    Diab Vasc Dis Res; 2009 Jul; 6(3):190-3. PubMed ID: 20368210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum uric acid and metabolic syndrome in type 2 diabetes.
    Bonakdaran S; Kharaqani B
    Curr Diabetes Rev; 2014 Mar; 10(2):113-7. PubMed ID: 24588601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
    Li L; Song Q; Yang X
    J Diabetes Res; 2019; 2019():3175418. PubMed ID: 31871945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity.
    Preumont V; Hermans MP; Brichard S; Buysschaert M
    Diabetes Metab; 2010 Sep; 36(4):293-8. PubMed ID: 20447851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
    Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
    Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.
    Hermans MP; Ahn SA; Rousseau MF
    Cardiovasc Diabetol; 2010 Dec; 9():88. PubMed ID: 21156040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotype.
    Gruson D; Rousseau MF; Ketelslegers JM; Hermans MP
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):653-60. PubMed ID: 20695946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
    Camara S; Bouenizabila E; Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2014; 8(3):145-51. PubMed ID: 25220917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid and diabetes: Is there a link?
    Katsiki N; Papanas N; Fonseca VA; Maltezos E; Mikhailidis DP
    Curr Pharm Des; 2013; 19(27):4930-7. PubMed ID: 23278493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.
    Van Beneden R; Gurné O; Selvais PL; Ahn SA; Robert AR; Ketelslegers JM; Pouleur HG; Rousseau MF
    J Card Fail; 2004 Dec; 10(6):490-5. PubMed ID: 15599839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of beta-cell function to compensate lack of insulin action in hyperuricemic subjects.
    Simental-Mendía LE; Rodríguez-Morán M; Guerrero-Romero F
    Diabetes Metab Res Rev; 2009 Sep; 25(6):535-41. PubMed ID: 19557736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The plasma levels of atrial natriuretic peptide and brain natriuretic peptide in type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor.
    Feng X; Gu Q; Gao G; Yuan L; Li Q; Zhang Y
    Ann Endocrinol (Paris); 2020 Oct; 81(5):476-481. PubMed ID: 32822653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to transform a metabolic syndrome score into an insulin sensitivity value?
    Hermans MP; Bouenizabila E; Ahn SA; Rousseau MF
    Diabetes Metab Res Rev; 2016 Jan; 32(1):87-94. PubMed ID: 26111860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric Acid in Metabolic and Cerebrovascular Disorders: A Review.
    Cortese F; Scicchitano P; Cortese AM; Meliota G; Andriani A; Truncellito L; Calculli G; Giordano P; Ciccone MM
    Curr Vasc Pharmacol; 2020; 18(6):610-618. PubMed ID: 31845632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Cell dysfunction is associated with metabolic syndrome severity in adults.
    Malin SK; Finnegan S; Fealy CE; Filion J; Rocco MB; Kirwan JP
    Metab Syndr Relat Disord; 2014 Mar; 12(2):79-85. PubMed ID: 24283920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes.
    Dencker M; Stagmo M; Dorkhan M
    Vasc Health Risk Manag; 2010 Jun; 6():373-82. PubMed ID: 20539839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus.
    Dullaart RP; Annema W; de Boer JF; Tietge UJ
    Atherosclerosis; 2012 Jun; 222(2):567-73. PubMed ID: 22541874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational diabetes mellitus worsens the profile of cardiometabolic risk markers and decrease indexes of beta-cell function independently of insulin resistance in nondiabetic women with a parental history of type 2 diabetes.
    Sokup A; Ruszkowska-Ciastek B; Walentowicz-Sadłecka M; Grabiec M; Rość D
    J Diabetes Res; 2014; 2014():743495. PubMed ID: 25097861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of beta cell function adjusted by anthropometric markers in patients with T2DM.
    Zhang M; Su Y; Quan L; Jiang S; Yao H
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1509-1516. PubMed ID: 32415755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.